Manager of RA Established Products
The department is currently being established and will be handling regulatory clinical activities within the established product portfolios.
The position holder will have a dotted line to CVP of RA Diabetes and Obesity and CVP of Biopharm in Denmark and in this way ensure functional alignment across the products and projects handled by the different departments.
The department is currently responsible for all regulatory CMC and device aspects of the HRT (hormone replacement therapy) portfolio, glucagon portfolio and growth hormone portfolio in addition to a several device products. The position holder will have a dotted line to VP of RA CMC & Devices in Denmark and in this way ensure functional alignment across the products and projects handled by the different departments.
The department is currently being established and responsibilities within the established product portfolios will transition from the Denmark unit to this team
The position will have a dotted line to VP of RA CMC & Devices in Denmark and in this way ensure functional alignment across the products and projects handled by the different departments.
You hold a Master of Science or other relevant Professional Degree (e.g. MD, PhD) combined with 5+ years’ experience from the pharmaceutical industry, preferably within global regulatory affairs organisation with project-based tasks.
You have strong people management skills, efficient negotiator and have good stakeholder management skills and lead by example and set direction. Furthermore, you motivate employees and keep engagement high in your department. You are flexible, quick to adapt and able to handle many responsibilities, while delivering results - Proactive and solution oriented. You hold good communication and presentation skills and is fluent in spoken and written English.
Experience : 5+ years
Qualification : MD, Ph.D
Location : Karnataka - Bangalore
Industry Type : Pharma/ Healthcare
Functional Area : Regulatory Affairs
End Date : 15th December, 2018
0 comments:
Post a Comment